The Effect of Oral Vaccination with Mycobacterium bovis BCG on the Development of Tuberculosis in Captive European Badgers (Meles meles)
Open Access
- 24 January 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 7, 6
Abstract
The European badger (Meles meles) is a reservoir host of Mycobacterium bovis and responsible for a proportion of the tuberculosis (TB) cases seen in cattle in the United Kingdom and Republic of Ireland. An injectable preparation of the bacillus Calmette-Guérin (BCG) vaccine is licensed for use in badgers in the UK and its use forms part of the bovine TB eradication plans of England and Wales. However, there are practical limitations to the widespread application of an injectable vaccine for badgers and a research priority is the development of an oral vaccine deliverable to badgers in bait. Previous studies reported the successful vaccination of badgers with oral preparations of 108 colony forming units (CFU) of both Pasteur and Danish strains of BCG contained within a lipid matrix composed of triglycerides of fatty acids. Protection against TB in these studies was expressed as a reduction in the number and apparent progression of visible lesions, and reductions in the bacterial load and dissemination of infection. To reduce the cost of an oral vaccine and reduce the potential for environmental contamination with BCG, it is necessary to define the minimal efficacious dose of oral BCG for badgers. The objectives of the two studies reported here were to compare the efficacy of BCG Danish strain in a lipid matrix with unformulated BCG given orally, and to evaluate the efficacy of BCG Danish in a lipid matrix at a ten-fold lower dose than previously evaluated in badgers. In the first study, both BCG unformulated and in a lipid matrix reduced the number and apparent progression of visible lesions and the dissemination of infection from the lung. In the second study, vaccination with BCG in the lipid matrix at a ten-fold lower dose produced a similar outcome, but with greater intra-group variability than seen with the higher dose in the first study. Further research is needed before we are able to recommend a final dose of BCG for oral vaccination of badgers against TB or to know whether oral vaccination of wild badgers with BCG will significantly reduce transmission of the disease.Keywords
Funding Information
- Department for Environment, Food and Rural Affairs (SE3247)
This publication has 27 references indexed in Scilit:
- Protection of Eurasian badgers (Meles meles) from tuberculosis after intra-muscular vaccination with different doses of BCGVaccine, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Comparison of a standard and a detailed postmortem protocol for detecting Mycobacterium bovis in badgersVeterinary Record, 2008
- Oral Vaccination of Guinea Pigs with aMycobacterium bovisBacillus Calmette-Guérin Vaccine in a Lipid Matrix Protects against Aerosol Infection with VirulentM. bovisInfection and Immunity, 2008
- Validation of the BrockTB Stat-Pak Assay for Detection of Tuberculosis in Eurasian Badgers ( Meles meles ) and Influence of Disease Severity on Diagnostic AccuracyJournal of Clinical Microbiology, 2008
- Evaluation of the anaesthetic effects of combinations of ketamine, medetomidine, romifidine and butorphanol in European badgers (Meles meles)Veterinary Anaesthesia and Analgesia, 2007
- Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation of Mycobacterium bovis: I. Pathology and bacteriologyResearch in Veterinary Science, 2007
- The safety and immunogenicity of Bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles)Veterinary Immunology and Immunopathology, 2006
- Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosisVaccine, 2006
- A selective oleic acid albumin agar medium for the cultivation ofMycobacterium bovisEpidemiology and Infection, 1977